SCHEMBL487401

SCHEMBL487401

OC(O)c1ccccc1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HSD17B10 Q99714 2/20 0.48
HPGD P15428 1/20 0.48
BCL2L1 Q07817 1/20 0.48
BACE1 P56817 1/20 0.44
CYP2A6 P11509 1/20 0.42
MAPK1 P28482 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KMT2A Q03164 2/20 0.41
BCAT2 O15382 1/20 0.40
ALOX5 P09917 1/20 0.38
DPP4 P27487 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
HNF4A P41235 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14471688 0.85 BACE1 (0.50) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL27968580 0.82 ALDH1A1 (0.41) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL27471399 0.81 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL2647486 0.81 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL3278303 0.79 KMT2A (0.47) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL7012982 0.79 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL7012979 0.79 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL31376578 0.79 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL2843781 0.79 ALDH1A1 (0.46) ALDH1A1HSD17B10HPGDBCL2L1BACE1
SCHEMBL4886483 0.78 LMNA (0.50) ALDH1A1HSD17B10HPGDBCL2L1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119864596-A Separator, preparation method thereof, battery and power utilization device 宁德时代新能源科技股份有限公司 2025-04-22 CN claimed
CN-106000470-B Catalyst and its preparation method and application for hydroformylation of olefin 四川大学 2018-12-14 CN claimed
US-12595334-B2 Compound, mixture, curable resin composition and cured product thereof, and method for producing compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-07 US disclosed
CN-119948079-A Multifunctional vinyl resin, method for producing the same, composition and cured product 日铁化学材料株式会社 2025-05-06 CN disclosed
CN-119864596-A Separator, preparation method thereof, battery and power utilization device 宁德时代新能源科技股份有限公司 2025-04-22 CN disclosed
CN-119604586-A Resin composition and cured product 日铁化学材料株式会社 2025-03-11 CN disclosed
CN-114650979-B Compound, mixture, curable resin composition, cured product thereof, and method for producing compound 日本化药株式会社 2024-09-17 CN disclosed
CN-111378093-B Epoxy resin, method for producing same, epoxy resin composition, and epoxy resin cured product 日铁化学材料株式会社 2024-09-03 CN disclosed
CN-118255955-A Resin, curable resin composition, cured product, resin material for solder resist, insulating material, and resist member DIC株式会社 2024-06-28 CN disclosed
CN-117460756-A Epoxy resin, epoxy resin composition and cured product thereof 日铁化学材料株式会社 2024-01-26 CN disclosed
CN-117279974-A Epoxy resin mixture, epoxy resin composition, and cured product thereof 日本化药株式会社 2023-12-22 CN disclosed
US-20090010603-A1 Resin Composition for Optical Packaging Material and Process for Preparing the Same, and Optical Packaging Material, Optical Packaging Component, and Optical Module NIPPON SHOKUBAI CO., LTD. (JP) 2009-01-08 US disclosed
US-20080085985-A1 CURABLE RESIN COMPOSITION, OPTICAL MATERIAL, AND METHOD FOR CONTROLLING OPTICAL MATERIAL NIPPON SHOKUBAI CO., LTD. (JP) 2008-04-10 US disclosed
CN-101027336-A Epoxy resin composition, cured product thereof, semiconductor sealing material, new phenolic resin, new epoxy resin, method for producing the new phenolic resin, and method for producing the new epoxy DAINIPPON INK & CHEMICALS (JP) 2007-08-29 CN disclosed
EP-1626065-A1 Resin composition, method of its composition, and cured formulation Nippon Shokubai Co., Ltd. (JP) 2006-02-15 EP disclosed
US-20060029811-A1 mixing a phenolic compound containing the inorganic microfine particle(SiO2) and a compound containing at least one of the glycidyl group and/or an epoxy group containing the inorganic microfine particle; fireproofing; good mechanical properties; heat resistance; automobiles, construction, electronics NIPPON SHOKUBAI CO., LTD. (JP) 2006-02-09 US disclosed
CN-1257869-A Diphenylphosphinomethyl substituted aminoalkyl phosphonic acid, its salts and their synthesis process XINAN NORMAL UNIV (CN) 2000-06-28 CN disclosed
EP-0699699-B1 Poly(4,5,9,10-tetrahydropyrene-2,7-diyl)-derivatives and their use as electroluminiscent materials AVENTIS RES & TECH GMBH & CO (DE) 1999-11-03 EP disclosed
US-5728480-A Poly(4,5,9,10-tetrahydropyrene-2,7-diyl) derivatives and their use as electroluminescence materials HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 US disclosed
EP-0699699-A1 Poly(4,5,9,10-tetrahydropyrene-2,7-diyl)-derivatives and their use as electroluminiscent materials HOECHST AKTIENGESELLSCHAFT (DE) 1996-03-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595334-B2 Compound, mixture, curable resin composition and cured product thereof, and method for producing compound RER1, RXRA, TERB1 ALDH1A1 1225/4885HSD17B10 2319/4885HPGD 2606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.